老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ionis Pharmaceuticals, Inc

77.64
-0.7298-0.93%
成交量：99.92萬
成交額：7,822.21萬
市值：125.76億
市盈率：-48.13
高：79.49
開：78.75
低：77.45
收：78.37
52周最高：83.61
52周最低：23.95
股本：1.62億
流通股本：1.61億
量比：0.51
換手率：0.62%
股息：- -
股息率：- -
每股收益(TTM):-1.6132
每股收益(LYR):-3.0358
淨資產收益率：-40.04%
總資產收益率：-5.68%
市淨率：20.35
市盈率(LYR):-25.57

資料載入中...

總覽公司新聞資訊公告
2021/03/23

重要事件披露

8-K - Current report
2021/02/24

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/24

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/14

SEC問詢函

CORRESP [Cover] - Correspondence
2020/12/31

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/12/18

重要事件披露

8-K - Current report
2020/12/09

重要事件披露

8-K - Current report
2020/11/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/04

重要事件披露

8-K - Current report
2020/10/13

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/10/13

重要事件披露

8-K - Current report
2020/10/02

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/09/24

SEC問詢函

CORRESP [Cover] - Correspondence
2020/08/31

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
更多